Table 4

Proportional distribution of tumour origin according to age in PJS patients compared to the general population

TumourAge (years)PJS cohort % (absolute numbers)General populationp Value
GI cancer (♂+♀)All ages48.8% (21/43)22.7%<0.001
5–3455.5% (5/9)*5%*<0.001*
35–5445.8% (11/24)15.3%<0.001
55+50% (5/10)25.3%0.073
GI cancer (♂)All ages72.2% (13/18)23.5%<0.001
5–3475% (3/4)5.9%0.001
35–5470% (7/10)23.6%0.002
55+75% (3/4)24.2%0.046
GI cancer (♀)All ages32% (8/25)21.7%0.214
5–3440% (2/5)4.2%0.017
35–5428.6% (4/14)10.3%0.048
55+33.3% (2/6)26.9%0.663
Gynaecological cancer (♀)All ages24% (6/25)11.5%0.051
5–3440% (2/5)13.8%0.144
35–5421.4% (3/14)12.6%0.406
55+16.7% (1/6)11.1%0.505
Breast cancer (♀)All ages20% (5/25)32.7%0.174
5–340% (0/5)22.1%0.593
35–5414.3% (2/14)48.1%0.014
55+50% (3/6)28%0.359
  • * That is 55.5% of cancers in the PJS cohort (♂+♀) aged 5–34 years concerned gastrointestinal (GI) cancers (five GI cancers among nine cancers diagnosed in this subgroup=55.5%), whereas this was 5% in the general population (♂+♀) aged 5–34 years (p<0.001).

  • Note: Cancers diagnosed in the PJS cohort before 1960 were not included in these analyses.